Self-medication of antibacterials without prescription (also called 'over-the-counter' use). A report of a working party of the British Society for Antimicrobial Chemotherapy

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 2, 1999, Pages 163-177

  Reeves, David S ^a   Finch, Roger G ^b   Bax, Richard P ^c   Davey, Peter G ^d   Po, Alan Li Wan ^e   Lingam, Geeta ^c   Mann, Stephen G ^f   Pringle, Michael A L ^g  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d NINEWELLS HOSPITAL   (United Kingdom)

^e ASTON UNIVERSITY   (United Kingdom)

^f JOHNSON AND JOHNSON   (United States)

^g Medical School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMPICILLIN; ANTHELMINTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; CHLORAMPHENICOL; CLINDAMYCIN; CORTICOSTEROID; DISINFECTANT AGENT; ERYTHROMYCIN; FLUCLOXACILLIN; FOSFOMYCIN; METICILLIN; MICONAZOLE; NITROFURANTOIN; NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOLNAFTATE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

AGE; ANTIBIOTIC RESISTANCE; BLOOD DYSCRASIA; CANDIDIASIS; CONJUNCTIVITIS; DIAGNOSTIC ERROR; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INFORMATION; DRUG LEGISLATION; DRUG MARKETING; DRUG MISUSE; DRUG PACKAGING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; ECOSYSTEM; EXTERNAL OTITIS; FETOTOXICITY; GENERAL PRACTICE; HUMAN; LICENSING; ORAL DRUG ADMINISTRATION; PATIENT GUIDANCE; PHARMACY; PREGNANCY; REVIEW; SELF MEDICATION; SKIN INFECTION; TOPICAL DRUG ADMINISTRATION; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUGS, NON-PRESCRIPTION; FEMALE; GREAT BRITAIN; HUMANS; LEGISLATION, DRUG; MALE; PATIENT EDUCATION; PREGNANCY; RISK ASSESSMENT; SELF MEDICATION;

EID: 0032792926     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.2.163     Document Type: Review

References (35)

1. The Council of European Communities. (1992). Concerning the Classification for the Supply of Medicinal Products for Human Use. Directive 92/26/EEC. HMSO, London.
2. Medicines Control Agency. (1997). Changing the Legal Classification in the United Kingdom of Prescription Only Medicine for Human Use. MAL 77. HMSO, London
3. Blenkinsopp, A. & Bradley, C. (1996). Patients, society and the increase in self medication. British Medical Journal 312, 629-32.
4. Bradley, C. & Blenkinsopp, A. (1996). The future for self medication. British Medical Journal 312, 835-7.
5. Bond, C. M. & Bradley, C. (1996). The interface between the community pharmacist and patients. British Medical Journal 312, 758-60.
6. Anon. (1994). Medicines without an NHS prescription. Drug and Therapeutics Bulletin 32, 4-5.
7. Thomas, D. H. V. & Noyce, P. R. (1996). The interface between self-medication and the NHS. British Medical Journal 312, 688-91.
8. World Health Organization. (1995). Report of the WHO Expert Committee on National Drug Policies: Contribution to Updating the WHO Guidelines for Developing National Drug Policies. WHO/DAP/95.9, p. 49. WHO, Geneva.
9. McNamee, D. (1994). Over-the-counter over Europe. Lancet 343, 1629.
10. Herxheimer, A., Upton, D., Spivey, P., Sharpe, D., Tugwell, C., Barrett, C. et al. (1993). Wanted: a formulary for self-care. Pharmaceutical Journal 251, 179.
11. Kennedy, J. G. (1996). Over-the-counter drugs: changing the roles of doctors and pharmacists. British Medical Journal 312, 593-4.
12. Medicines Control Agency. (1996). Administration and Supply of Prescription Only and Pharmacy Medicines by State Registered Chiropodists. MLX228. MCA, London.
13. European Commission. (1997). A Guideline on Changing the Classification for the Supply of a Medicinal Product for Human Use. Draft 3; issued 12 June 1997 by the Directorate General III.
14. Finch, R. G. & Reeves, D. S. (1996). Working party will see whether antimicrobials should be available. British Medical Journal 313, 115.
15. Anon. (1996). POM to P for antibiotics: working party established. Pharmaceutical Journal 257, 242.
16. Sandham, P. (1996). Antibiotics - surely some mistake! Pharmaceutical Journal 257, 304.
17. Finch, R. G. & Reeves, D. S. (1996). Working party established. Pharmaceutical Journal 257, 504.
18. Anon. (1994). Over-the-counter drugs. Lancet 343, 1374-5.
19. Steinhoff, M. C., El Khalek, M. K. A., Khallaf, N., Hamza, H. S., El Ayadi, A., Orabi, A. et al. (1997). Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children. Lancet 350, 918-21.
20. Kaiser, L., Lew, D., Hirschel, B., Auckenthaler, R., Morabia, A., Heald, A. et al. (1996). Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 34, 1507-10.
21. Little, P., Williamson, I., Warner, G., Gould, C., Gantley, M. & Kinmonth, A. L. (1997). Open randomised trial of prescribing strategies in managing sore throat. British Medical Journal 314, 722-7.
22. World Health Organization. (1996). The World Health Report 1996: Fighting Disease. Fostering Development. WHO, Geneva.
23. MacGowan, J. E. (1987). Is antimicrobial resistance in hospital micro-organisms related to antibiotic use? Bulletin of the New York Academy of Medicine 63, 253-68.
24. Seppala, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K. et al. (1997).The effects of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. New England Journal of Medicine 337, 441-6.
25. O'Brien, T. F. (1987). Resistance of bacteria to antibacterial agents: report of Task Force 2. Reviews of Infectious Diseases 9 (Suppl. 3), S244-60.
26. Reeves, D. S. (1994). Trends in resistance to antibacterials. In Rapid Methods and Automation in Microbiology and Immunology (Spencer, R. C., Wright, E. P. & Newsom, S. W. B., Eds), pp. 489-502. Intercept, Andover.
27. European Agency for the Evaluation of Medicinal Products. (1997). Note for Guidance on the Pharmacodynamic Section of the SPC for Antibacterial Medicinal Products. MCA Eurodirect Publication No. EWP/520/96. MCA Eurodirect Publications, London.
28. Leibovici, L. & Wysenbeek, A. J. (1991). Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a meta-analysis of randomised trials. Quarterly Journal of Medicine 78, 43-57.
29. Norrby, S. R. (1990). Short-term treatment of uncomplicated lower urinary tract infections in women. Reviews of Infectious Diseases 12, 458-67.
30. Hallas, J., Gram, L. F., Grodum, E., Damsbo, N., Brosen, K., Haghfelt, T. et al. (1991). Drug related admissions to medical wards: a population based survey. British Journal of Clinical_Pharmacology 33, 61-8.
31. Lancaster, T., Swart, A. M. & Jick, H. (1998). Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. British Medical Journal 316, 667.
32. Wiholm, B.-E., Kelly, J. P., Kaufman, D., Issaragrisil, S., Levy, M., Anderson, T. et al. (1998) Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. British Medical Journal 316, 666.
33. Doona, M. & Walsh, J. B. (1998). Topical chloramphenicol is an outmoded treatment. British Medical Journal 316, 1903.
34. European Commission. (1998). A Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use. DG III Industry. Published 29 September 1998; proposed operational date January 1999.
35. Anon. (1994). The Medicines (Advertising) Regulation 1994. Statutory Instrument no. 1932. HMSO, London.